ARTICLE | Clinical News

Encore preclinical data

April 17, 2000 7:00 AM UTC

Encore published in Life Sciences that in a mouse model of FAP, treatment with E-7869 cured intestinal adenomas, which are precursors to colon cancer. Separately, Encore published in Cancer Research that E-7869 reduced the incidence of primary prostate tumors and metastatic disease in a mouse model of human prostate cancer. ...